Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing

This document is a response to comments for MolDX: DecisionDX-Melanoma (LCD L37748), renamed to MolDX: Melanoma Risk Stratification Molecular Testing, and provides comment/notice/effective dates. It does not contain clinical coverage criteria, limitations, documentation requirements, or frequency limits; refer to LCD L37748 for the detailed coverage policy.